Targeted Oncology
Advertisement
Articles by Targeted Oncology
Experts in the management of diffuse large B-cell lymphoma (DLBCL) discuss the use of novel CD19-antibody mono- and combination therapies to treat relapsed/refractory subpopulations.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Lung Cancer News Roundup: June 2026
2
Zoldonrasib Combos, Including With Daraxonrasib, Yield High Response Rates in PDAC
3
Speed Is the Story: How Sequencing the Human Genome Transformed Cancer Care
4
Examining the Strongest Options for Heavily Pretreated Myeloma After Bispecific Therapy
5